|
|
|
--
|
2025-09-03 |
A轮 |
2亿美元 |
GV
EXOR
AI Life Sciences Investments
T. Rowe Price
OrbiMed
Ajax Health
ARCH Venture Partners
Fidelity Investments
Casdin Capital
Aisling Capital
KKR
Rock Springs Capital
|
|
|
|
新药研发 · 肿瘤
|
2024-12-19 |
IPO后其它轮次 |
1610万美元 |
Aisling Capital
New Enterprise Associate
Blue Owl Healthcare Opportunities
|
|
|
|
新药研发 · 生物科技
|
2024-05-02 |
IPO后其它轮次 |
2亿美元 |
GV
Surveyor Capital
Longwood Fund
Deerfield
Enavate Sciences
Cormorant Asset Management
Omega Funds
Casdin Capital
Aisling Capital
Wellington Management
EcoR1 Capital
|
|
|
|
--
|
2023-12-12 |
C轮 |
1.65亿美元 |
TPG Life Sciences Innovations
The Rise Fund
Deerfield
Fairmount
Braidwell
Aisling Capital
|
|
|
|
--
|
2023-08-16 |
IPO后其它轮次 |
2.85亿美元 |
TCGX
Surveyor Capital
RA Capital
Paradigm BioCapital
Armistice Capital
Logos Capital
Aisling Capital
PFM Health Sciences
Laurion Capital Management
维梧资本
Soleus Capital
|
|
|
|
--
|
2023-02-07 |
B轮 |
6200万美元 |
Cormorant Asset Management
Mass General Brigham Ventures
OrbiMed
Aisling Capital
Sector Asset Management
Northpond Ventures
Alexandria Venture Investments
|
|
|
|
--
|
2022-09-12 |
C轮 |
9000万美元 |
Drive Capital
Aisling Capital
|
|
|
|
--
|
2022-06-14 |
B轮 |
6500万美元 |
SR One
Taiho Ventures
8VC
BVF Partners
pfizer
Mission BioCapital
Aisling Capital
Alexandria Venture Investments
Revelation Partners
ArrowMark Partners
HBM Healthcare Investments
|
|
|
|
新药研发
|
2021-11-03 |
B轮 |
7500万美元 |
GordonMD Global Investments
Delos Capital
Avego Bioscience Capital
EPIQ Capital Group
Pontifax
Granite Point Capital
RA Capital
Altium Capital
LifeSci Venture Partners
Lumira Ventures
CAM Capital
Adage Capital Management
Amzak Health
Sixty Degree Capital
Aisling Capital
Fonds de Solidarite FTQ
GRA Venture Fund
Soleus Capital
Heartland Healthcare Capital
Domain Partners
|
|
|
|
--
|
2021-09-23 |
A轮 |
7200万美元 |
Monashee Investment Management
National Resilience
Cormorant Asset Management
Mass General Brigham Ventures
OrbiMed
Ridgeback Capital
Aisling Capital
Northpond Ventures
Sectoral Asset Management
|
|
|
|
--
|
2021-07-15 |
B轮 |
1.72亿美元 |
Abingworth
Falcon Edge Capital
RiverVest
Velosity Capital
Lightchain
Tybourne Capital Management
Fidelity Investments
Aisling Capital
ICG
Alexandria Venture Investments
Sands Capital Ventures
醴泽资本
|
|
|
|
新药研发
|
2021-04-12 |
B轮 |
9600万美元 |
Delos Capital
Pontifax
Granite Point Capital
RA Capital
Altium Capital
LifeSci Venture Partners
Lumira Ventures
CAM Capital
Adage Capital Management
Amzak Health
Sixty Degree Capital
Aisling Capital
DOMAIN
Soleus Capital
|
|
|
|
--
|
2021-03-12 |
C轮 |
9500万美元 |
GV
Cambridge Asset Management
RTW Investments
Cormorant Asset Management
T. Rowe Price
Amzak Health
Sixty Degree Capital
Fidelity Investments
Versant Ventures
Casdin Capital
Avoro Capital Advisors
Aisling Capital
New Enterprise Associate
BlackRock
HBM Healthcare Investments
|
|
|
|
--
|
2021-01-06 |
A轮 |
5600万美元 |
Clifton Capital Management
RTW Investments
Boxer Capital
Cormorant Asset Management
Logos Capital
Aisling Capital
Rock Springs Capital
|
|
|
|
--
|
2020-12-09 |
B轮 |
9500万美元 |
Lundbeckfonden Ventures
Pappas Capital
Abingworth
Novo Ventures
RiverVest
Amzak Health
Aisling Capital
New Enterprise Associate
Rock Springs Capital
|
|
|
|
--
|
2020-10-06 |
B轮 |
1.15亿美元 |
Viking Global Investors
Surveyor Capital
Longitude Capital
Cormorant Asset Management
Blackstone Life Sciences
Pamoja Capital
Invus
QIMING Venture Partners USA
Logos Capital
Aisling Capital
Eventide Asset Management
BlackRock
|
|
|
|
--
|
2020-09-25 |
B轮 |
9600万美元 |
Cormorant Capital
Versant Ventures
Aisling Capital
HBM Partners
|
|
|
|
--
|
2020-07-21 |
A轮 |
3250万美元 |
Driehaus Capital Management
Vertex Ventures
QIMING Venture Partners USA
BVF Partners
Aisling Capital
|
|
|
|
新药研发
|
2020-07-17 |
IPO后其它轮次 |
1.59亿英镑 |
Abingworth
Access Industries
Samsara BioCapital
RA Capital
Perceptive Advisors
Novo Holdings
OrbiMed
Acorn Bioventures
Aisling Capital
New Enterprise Associate
PBM Capital Group
Sphera Funds Management
维梧资本
Soleus Capital
Foresite Capital
|
|
|
|
--
|
2020-02-20 |
B轮 |
8800万美元 |
Abingworth
Surveyor Capital
RiverVest
Novo Holdings
Omega Funds
Aisling Capital
Rock Springs Capital
Sands Capital Ventures
HealthCap Partners
|
|
|
|
--
|
2019-10-28 |
A轮 |
2.75亿美元 |
Pavilion Capital
EDBI
Omega Funds
Aisling Capital
The Baupost Group
Altitude Life Science Ventures
|
|
|
|
--
|
2019-04-22 |
C轮 |
1.42亿美元 |
Longitude Capital
Boxer Capital
Perceptive Advisors
Aisling Capital
Pentwater Capital
Novartis
维梧资本
|
|
|
|
新药研发 · 生物科技
|
2019-01-23 |
D轮 |
2.992亿美元 |
Sequoia Capital
Viking Global Investors
Cormorant Capital
Perceptive Advisors
Kohlberg Kravis Roberts
American International Group
Aisling Capital
Hercules Capital
|
|
|
|
生物科技
|
2018-09-12 |
C轮 |
1.25亿人民币 |
Redmile Group
Samsara BioCapital
Boxer Capital
Cormorant Asset Management
Tekla Capital Management
Aisling Capital
Tavistock Group
Wellington Management
EcoR1 Capital
|
|
|
|
传统器械
|
2018-04-03 |
IPO后其它轮次 |
5000万美元 |
Aisling Capital
|
|
|
|
基因
|
2018-02-04 |
B轮 |
6000万美元 |
Cormorant Asset Management
五源资本
Clarus Ventures
Aisling Capital
SV Health Investors
Eventide Asset Management
Brace Pharma Capital
Citadel
Atlas Venture
SVB Securities
|
|
|
|
新药研发 · 肿瘤 · 生物科技
|
2017-11-13 |
C轮 |
1.07亿美元 |
GV
Taiho Ventures
高瓴资本
Celgene
Invus
BVF Partners
德诚资本
Aisling Capital
The Column Group
DROIA
Wellington Management
Foresite Capital
EcoR1 Capital
SVB Securities
|
|
|
|
生物科技 · 新药研发
|
2017-10-10 |
IPO后其它轮次 |
6000万美元 |
Dafna Capital Management
Venrock
NLVP
Sofinnova Investments
Omega Funds
Aisling Capital
New Enterprise Associate
Sphera Global Healthcare Fund
|
|
|
|
生物科技 · 植物提取
|
2017-09-26 |
PE |
4850万美元 |
CAM Capital
Aisling Capital
Amzak Capital Management
|
|
|
|
新药研发 · 生物科技
|
2017-09-13 |
C轮 |
1.35亿美元 |
Viking Global Investors
Perceptive Advisors
Kohlberg Kravis Roberts
American International Group
Aisling Capital
|
|
|
|
--
|
2017-07-18 |
C轮 |
5000万美元 |
Presidio Partners
F-Prime Capital
Novo Holdings
Bay City Capital
Aisling Capital
VenBio Partners
Rock Springs Capital
维梧资本
Remeditex Ventures
|
|
|
|
传统器械
|
2017-06-05 |
股权融资 |
1.18亿美元 |
Windham Venture Partners
Lightstone Ventures
Vertex Ventures
Aisling Capital
New Enterprise Associate
SightLine Partners
|
|
|
|
医药企业 · 新药研发 · 生物科技
|
2017-04-11 |
IPO后其它轮次 |
8000万美元 |
Osage University Partners
Aperture Venture Partners
Litmore Capital
CT Innovations
Venrock
Knoll Capital Management
RA Capital
Aisling Capital
Rock Springs Capital
维梧资本
|
|
|
|
医药企业
|
2017-03-31 |
C轮 |
2600万美元 |
F-Prime Capital
OrbiMed
Golden Triangle Angel Network
Aisling Capital
|
|
|
|
新药研发
|
2017-03-07 |
未公开 |
2000万美元 |
Osage University Partners
Aperture Venture Partners
Litmore Capital
CT Innovations
Venrock
Knoll Capital Management
RA Capital
Aisling Capital
Rock Springs Capital
维梧资本
|
|
|
|
新药研发
|
2016-11-01 |
未公开 |
8000万美元 |
Osage University Partners
Aperture Venture Partners
Litmore Capital
CT Innovations
Venrock
Knoll Capital Management
RA Capital
Aisling Capital
Rock Springs Capital
维梧资本
|
|
|
|
新药研发
|
2016-06-20 |
IPO后其它轮次 |
4470万英镑 |
Andera Partners
Abingworth
Novo Ventures
Novo Holdings
OrbiMed
Arthurian Life Sciences
Aisling Capital
维梧资本
|
|
|
|
--
|
2016-06-20 |
未公开 |
6000万美元 |
Advent Life Sciences
Novo A/S
Novartis Venture Fund
Aisling Capital
Sunstone Life Science Ventures
Brace Pharma Capital
Merifin Capital
Sectoral Asset Management
|
|
|
|
生物科技 · 基因
|
2016-01-12 |
C轮 |
4000万美元 |
Redmile Group
Deerfield
毓承资本
Polaris Partners
Fidelity Investments
Casdin Capital
Aisling Capital
Alexandria Venture Investments
|
|
|
|
肿瘤 · 生物科技
|
2015-07-24 |
未公开 |
2700万美元 |
Xeraya Capital
OrbiMed
Fidelity International
Montrose Capital Partners
Aisling Capital
Kearny Venture Partners
|
|
|
|
新药研发 · 生物科技
|
2015-05-31 |
股权融资 |
1596.854万美元 |
Dafna Capital Management
Venrock
Pura Vida
Broadfin Capital
OrbiMed
Dexcel Pharma Technologies
Aisling Capital
Sphera Funds Management
|
|
|
|
生物科技
|
2015-03-12 |
B轮 |
8000万美元 |
Longitude Capital
RA Capital
Fidelity Investments
Aisling Capital
Foresite Capital
|
|
|
|
医药企业 · 健康管理
|
2015-01-20 |
IPO后其它轮次 |
2000万美元 |
RA Capital
ProQuest Investments
CAM Capital
Aisling Capital
|
|
|
|
生物科技 · 基因
|
2014-10-27 |
B轮 |
5300万美元 |
Redmile Group
毓承资本
Polaris Partners
Flagship Pioneering
ARCH Venture Partners
Aisling Capital
Alexandria Venture Investments
|
|
|
|
生物科技 · 医药企业
|
2014-08-21 |
C轮 |
5100万美元 |
Sabby Capital
Canaan Partners
Bay City Capital
Aisling Capital
New Enterprise Associate
Apple Tree Partners
Rock Springs Capital
|
|
|
|
--
|
2014-07-18 |
IPO后其它轮次 |
9300万美元 |
Abingworth
Omega Funds
Aisling Capital
The Baupost Group
|
|
|
|
生物科技 · 新药研发
|
2014-06-30 |
A轮 |
3200万美元 |
Frazier Management
5AM Ventures
Aisling Capital
InterWest Partners
|
|
|
|
生物科技 · 眼科
|
2014-06-16 |
D轮 |
1000万美元 |
Correlation Ventures
Venrock
Aisling Capital
|
|
|
|
肿瘤 · 基因
|
2014-05-06 |
B轮 |
2400万美元 |
OrbiMed
Aisling Capital
|
|
|
|
医药企业
|
2014-02-19 |
E轮 |
5500万美元 |
NLVP
Advent Life Sciences
Sofinnova Investments
Aisling Capital
|
|
|
|
医药企业 · 新药研发 · 肿瘤
|
2013-10-16 |
A轮 |
3000万美元 |
Topspin Fund
OrbiMed
Aisling Capital
The Column Group
VenBio Partners
|
|
|
|
医药企业
|
2013-10-08 |
D轮 |
2000万美元 |
NLVP
Amunix
Index Ventures
Sofinnova Investments
Aisling Capital
Advent Venture Partners
|
|
|
|
肿瘤 · 基因
|
2013-10-03 |
A轮 |
3300万美元 |
OrbiMed
Aisling Capital
|
|
|
|
--
|
2013-10-02 |
未公开 |
8700万美元 |
Florida Growth Fund
Aisling Capital
PDL BioPharma
|
|
|
|
--
|
2013-07-09 |
未公开 |
4550万美元 |
DeNovo Ventures
AMOREPACIFIC Ventures
Athyrium Capital Management
Technology Partners
Bay City Capital
Morgan Stanley Alternative Investment Partners
Aisling Capital
维梧资本
|
|
|
|
医药企业 · 新药研发
|
2013-04-25 |
未公开 |
3300万美元 |
Alta Partners
Longitude Capital
Asset Management Ventures
Arboretum Ventures
Aisling Capital
DOMAIN
|
|
|
|
医药企业
|
2013-01-15 |
C轮 |
2500万美元 |
NLVP
Index Ventures
Aisling Capital
Advent Venture Partners
|
|
|
|
--
|
2012-10-04 |
D轮 |
5000万美元 |
Topspin Fund
OrbiMed
Aisling Capital
The Column Group
VenBio Partners
|
|
|
|
医药企业 · 健康管理
|
2012-07-19 |
C轮 |
4000万美元 |
Kaiser Permanente Ventures
Care Capital
ProQuest Investments
Patricia Industries
Aisling Capital
Novitas Capital
|
|
|
|
--
|
2012-03-12 |
未公开 |
2400万美元 |
Florida Growth Fund
Aisling Capital
|
|
|
|
传统器械
|
2010-06-03 |
D轮 |
2500万美元 |
Aisling Capital
|
|
|
|
--
|
2010-04-22 |
B轮 |
2200万美元 |
OrbiMed
Aisling Capital
The Column Group
|
|
|
|
医药企业 · 新药研发
|
2008-04-30 |
A轮 |
2275万美元 |
Alta Partners
Arboretum Ventures
Aisling Capital
DOMAIN
|
|
|
|
--
|
2007-10-26 |
IPO后其它轮次 |
4000万美元 |
Pacific Growth Equities
D. E. Shaw & Co.
Aisling Capital
IBT管理公司
|
|
|
|
新药研发 · 医药企业 · 生物科技
|
2007-07-01 |
B轮 |
1000万美元 |
Intersouth Partners
I. Wistar Morris III Optimer Pharmaceuticals
Aisling Capital
|
|
|
|
生物科技
|
2002-10-28 |
B轮 |
5000万美元 |
华盈基金
Perseus-Soros Biopharmaceutical Fund
Bay City Capital
Aisling Capital
GGV Capital
维梧资本
|